scorecardresearch
Follow Us:
Sunday, May 22, 2022

WHO suspends UN supply of Bharat Biotech’s Covaxin vaccine for COVID-19

The WHO asked countries that have received the vaccine to take appropriate actions, according to the statement, but did not specify what the appropriate actions would be.

By: Reuters |
Updated: April 3, 2022 6:30:33 pm
The WHO said the vaccine is effective and no safety concerns exist, but the suspension of production for export will result in the interruption of Covaxin supply. (Express photo by Partha Paul)

The World Health Organization said on Saturday it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India’s Bharat Biotech, to allow the manufacturer to upgrade facilities and address deficiencies found in an inspection.

🗞️ Subscribe Now: Get Express Premium to access the best Election reporting and analysis 🗞️

The WHO asked countries that have received the vaccine to take appropriate actions, according to the statement, but did not specify what the appropriate actions would be.

The WHO said the vaccine is effective and no safety concerns exist, but the suspension of production for export will result in the interruption of Covaxin supply. It said the suspension is in response to the outcomes of WHO post emergency use listing (EUL) inspection conducted from March 14 to 22, and the vaccine maker has indicated its commitment to suspend production of Covaxin for export.

Best of Express Premium

FY22: As Covid curbs ease, outward remittances up 55% to all-time highPremium
‘In Mathura, Radha ki chunari bhi Salma silti hai’Premium
A Letter From Varanasi: ‘It’s our waqt… Ayodhya will happen in Kash...Premium
Evil under the sunPremium

Bharat Biotech did not immediately respond to a request for comment sent outside business hours. On Friday, the vaccine manufacturer said it was slowing production of Covaxin, as demand was dropping along with a fall in infections and wider immunisation coverage in the country.

The WHO said that the company has “committed to comply by addressing the GMP deficiencies and is developing a corrective and preventive action plan, for submission to the Drugs Controller General of India (DCGI) and WHO”.

For all the latest World News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.
Advertisement
Advertisement
Advertisement
Advertisement